Results 201 to 210 of about 176,845 (241)
Molecular, genetic, virological, and biochemical analysis in combination with global proteome and phosphoproteome profiling and functional assays were applied to study the role of PR130 in the context of HSV‐1 replication. The observations reveal that host‐intrinsic mechanisms regulate HSV‐1 replication and highlight PR130 as a susceptibility factor of
Johannes Jungwirth +10 more
wiley +1 more source
This study presents a single‐cell atlas of pseudomyxoma peritonei spanning primary and paired metastatic lesions. Distinct epithelial substates, stromal remodeling, immune exclusion, lipid metabolic reprogramming, and a candidate angiogenic network were identified in metastatic lesions.
Xi Li +14 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cross-presentation of Exogenous Antigens
Transfusion Clinique et Biologique, 2019Presentation of exogenous antigens loaded on major histocompatibility complex class I molecules by antigen presenting cells, termed cross-presentation, is essential for the induction of CD8+ T cells and is performed mainly by specialized dendritic cell subsets.
B, Li, L, Hu
openaire +2 more sources
Pathways for antigen cross presentation
Springer Seminars in Immunopathology, 2004Dendritic cells (DCs) have the unique ability to capture cellular tissue antigens, and to present them on MHC class I molecules to antigen-specific CD8(+) T lymphocytes after migration to the draining lymph nodes. This process, called "cross presentation" can lead either to the tolerization or activation of antigen-specific CD8(+) T cells.
Guermonprez, P, Amigorena, S
openaire +3 more sources
Cross-Presentation of Antigens by Dendritic Cells
Critical Reviews™ in Immunology, 2002T lymphocytes recognize antigen presented on the surface of antigen-presenting cells byMHC class I and class II molecules. Classically, MHC class I molecules present self- or pathogen-derived antigens that are synthesized within the cell, whereas exogenous antigens derived via endocytic uptake are loaded onto MHC class II molecules for presentation to ...
Belz, Gabrielle T. +2 more
openaire +3 more sources
Phagosomes are competent organelles for antigen cross-presentation
Nature, 2003The ability to process microbial antigens and present them at the surface of cells is an important aspect of our innate ability to clear infections. It is generally accepted that antigens in the cytoplasm are loaded in the endoplasmic reticulum and presented at the cell surface on major histocompatibility complex (MHC) class I molecules, whereas ...
Mathieu, Houde +9 more
openaire +2 more sources
Pathways of MHC I cross-presentation of exogenous antigens
Seminars in Immunology, 2023Phagocytes, particularly dendritic cells (DCs), generate peptide-major histocompatibility complex (MHC) I complexes from antigens they have collected from cells in tissues and report this information to CD8 T cells in a process called cross-presentation. This process allows CD8 T cells to detect, respond and eliminate abnormal cells, such as cancers or
Freidrich M, Cruz +2 more
openaire +2 more sources
The ins-and-outs of endosomal antigens for cross-presentation
Current Opinion in Immunology, 2014The efficiency of antigen cross-presentation, which is the presentation of extracellular antigens on MHC I molecules, critically depends on the stability of the internalized antigens. Since rapid degradation within the lysosomal compartment impairs cross-presentation, potent cross-presenting cells display several mechanisms to prevent activation of ...
Verena, Schuette, Sven, Burgdorf
openaire +2 more sources
Neonatal and adult microglia cross‐present exogenous antigens
Glia, 2007AbstractSome observations have suggested that cells from the central nervous system (CNS) could present exogenous antigens on major histocompatibility complex (MHC) class I molecules to CD8+ T cells (a process called cross‐presentation). Microglia are the major myeloid immunocompetent cells of the CNS.
Beauvillain, Celine +8 more
openaire +3 more sources
Engineering nanoparticulate vaccines for enhancing antigen cross-presentation
Current Opinion in Biotechnology, 2020Efficient cross-presentation is pivotal for vaccination against cancer and infection by intracellular virus and bacteria. Recently, various types of nanoparticle vaccines have been developed and investigated for efficiently and specifically improving cross-presentation and CD8+ T cell priming.
Guangsheng, Du, Xun, Sun
openaire +2 more sources

